Evidence map›Paper›PMID 25057966›Full record

ArticlePloS one2014

Cytotoxic and pathogenic properties of Klebsiella oxytoca isolated from laboratory animals.

Alison Darby, Kvin Lertpiriyapong, Ujjal Sarkar, Uthpala Seneviratne, Danny S Park, Eric R Gamazon, Chara Batchelder, Cheryl Cheung, Ellen M Buckley, Nancy S Taylor and 4 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 57 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Antibiotic Resistance in Enterococci andPathogens (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Alison DarbyDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Kvin LertpiriyapongDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Ujjal SarkarDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge. Massachusetts, United States of America.
Uthpala SeneviratneDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge. Massachusetts, United States of America.
Danny S ParkPharmaceutical Sciences and Pharmacogenomics Graduate Program, University of California, San Francisco, California, United States of America.
Eric R GamazonSection of Genetic Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois, United States of America.
Chara BatchelderDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Cheryl CheungDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Ellen M BuckleyDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Nancy S TaylorDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Zeli ShenDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Steven R TannenbaumDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge. Massachusetts, United States of America; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
John S WishnokDepartment of Biological Engineering, Massachusetts Institute of Technology, Cambridge. Massachusetts, United States of America.
James G FoxDivision of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America; Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge. Massachusetts, United States of America.
Massachusetts Institute of Technology · USUniversity of California, San Francisco · USUniversity of Chicago · US

Funding

TOXICOLOGY CORE UNITP30ES002109 · NIEHS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LEVINE, STUART S · 1985 to 2020
$25.6M
Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
POSTDOCTORAL TRAINING IN COMPARATIVE MEDICINET32RR007036 · NCRR · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI FOX, JAMES G · 1988 to 2011
$3.6M
NCATS NIH HHS UL1 TR000430NCRR NIH HHS T32 RR007036NCRR NIH HHS T32-RR007036NIEHS NIH HHS P30 ES002109NIEHS NIH HHS P30-ES002109
6 · The paper itself

Abstract

Klebsiella oxytoca is an opportunistic pathogen implicated in various clinical diseases in animals and humans. Studies suggest that in humans K. oxytoca exerts its pathogenicity in part through a cytotoxin. However, cytotoxin production in animal isolates of K. oxytoca and its pathogenic properties have not been characterized. Furthermore, neither the identity of the toxin nor a complete repertoire of genes involved in K. oxytoca pathogenesis have been fully elucidated. Here, we showed that several animal isolates of K. oxytoca, including the clinical isolates, produced secreted products in bacterial culture supernatant that display cytotoxicity on HEp-2 and HeLa cells, indicating the ability to produce cytotoxin. Cytotoxin production appears to be regulated by the environment, and soy based product was found to have a strong toxin induction property. The toxin was identified, by liquid chromatography-mass spectrometry and NMR spectroscopy, as low molecular weight heat labile benzodiazepine, tilivalline, previously shown to cause cytotoxicity in several cell lines, including mouse L1210 leukemic cells. Genome sequencing and analyses of a cytotoxin positive K. oxytoca strain isolated from an abscess of a mouse, identified genes previously shown to promote pathogenesis in other enteric bacterial pathogens including ecotin, several genes encoding for type IV and type VI secretion systems, and proteins that show sequence similarity to known bacterial toxins including cholera toxin. To our knowledge, these results demonstrate for the first time, that animal isolates of K. oxytoca, produces a cytotoxin, and that cytotoxin production is under strict environmental regulation. We also confirmed tilivalline as the cytotoxin present in animal K. oxytoca strains. These findings, along with the discovery of a repertoire of genes with virulence potential, provide important insights into the pathogenesis of K. oxytoca. As a novel diagnostic tool, tilivalline may serve as a biomarker for K oxytoca-induced cytotoxicity in humans and animals through detection in various samples from food to diseased samples using LC-MS/MS. Induction of K. oxytoca cytotoxin by consumption of soy may be in part involved in the pathogenesis of gastrointestinal disease.

Indexed as

AnimalsBacterial Secretion SystemsBacterial ToxinsBenzodiazepinonesCell DeathCell LineCell SurvivalGlycine maxHaplorhiniHeLa CellsHumansKlebsiella InfectionsKlebsiella oxytocaMicePlant ExtractsRatsBacterial Secretion SystemsBacterial ToxinsBenzodiazepinonesPlant Extractstilivalline

Identifiers

PMID25057966
PMCPMC4109914
OpenAlexW2007408642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.